首页 | 本学科首页   官方微博 | 高级检索  
     

丹红注射液治疗糖尿病合并冠心病的Meta分析
引用本文:汤爽,张丹,韩霜,陈亚红,马宝南,刘传鑫,张晨宁. 丹红注射液治疗糖尿病合并冠心病的Meta分析[J]. 中国中药杂志, 2021, 0(1): 237-246
作者姓名:汤爽  张丹  韩霜  陈亚红  马宝南  刘传鑫  张晨宁
作者单位:北京中医药大学中药学院;军事科学院军事医学研究所毒物药物研究所抗毒药物与毒理学国家重点实验室神经精神药理学北京市重点实验室;十堰市太和医院武当中医药研究所
基金项目:北京中医药大学研究生项目(2019-JYB-XS-077);湖北省卫生健康委科研项目(WJ2017F079)。
摘    要:为系统评价丹红注射液联合常规治疗对比常规治疗,改善糖尿病合并冠心病的临床疗效与安全性.该研究通过中国知网、万方、维普、PubMed、Wed of Science、Cochrane Library,全面检索丹红注射液治疗糖尿病合并冠心病的随机对照试验(RCT)的中英文文献,限定时间为建库至2020年1月1日.严格按照纳排...

关 键 词:丹红注射液  糖尿病合并冠心病  Meta分析  有效性  安全性

Meta-analysis of Danhong Injection in treatment of diabetes mellitus complicated with coronary heart disease
TANG Shuang,ZHANG Dan,HAN Shuang,CHEN Ya-hong,MA Bao-nan,LIU Chuan-xin,ZHANG Chen-ning. Meta-analysis of Danhong Injection in treatment of diabetes mellitus complicated with coronary heart disease[J]. China Journal of Chinese Materia Medica, 2021, 0(1): 237-246
Authors:TANG Shuang  ZHANG Dan  HAN Shuang  CHEN Ya-hong  MA Bao-nan  LIU Chuan-xin  ZHANG Chen-ning
Affiliation:(School of Traditional Chinese Materia Medica,Beijing University of Chinese Medicine,Beijing 100029,China;State Key Laboratory of Antitoxic Drugs and Toxicology,Beijing Key Laboratory of Neuropsychopharmacology,Institute of Toxicology,Academy of Military Medicine,Academy of Military Sciences,Beijing 100850,China;Institute of Wudang Traditional Chinese Medicine,Taihe Hospital,Affiliated Hospital of Hubei University of Medicine,Shiyan 442000,China)
Abstract:To systematically evaluate the clinical efficacy and safety of Danhong Injection combined with conventional therapy in improving diabetes mellitus complicated with coronary heart disease.Based on the online literature database(CNKI,Wanfang,VIP,PubMed,Web of Science,Cochran Library),the Chinese and English papers about the randomized controlled trial(RCT)of Danhong Injection in the treatment of diabetes mellitus complicated with coronary heart disease were searched comprehensively from the establishment of the databases to January 1,2020.The papers were screened strictly according to the inclusion and exclusion criteria.Based on Jadad scale,the risk assessment of literature was carried out,and Meta-analysis was performed by STATA 12.0 software.Seventeen RCTs were included,involving 1453 patients.The results of Meta-analysis showed that the combination of Danhong Injection and conventio-nal treatment could improve the clinical comprehensive effective rate(RR=1.47,95%CI[1.38,1.58],P<0.0001),electrocardiogram(ECG)efficiency(RR=1.30,95%CI[1.16,1.46],P<0.0001),efficiency of the angina pectoris(RR=1.41,95%CI[1.25,1.58],P<0.0001),cholesterol level(SMD=-1.05,95%CI[-1.95,-0.16],P=0.02),low-density lipoprotein(LDL)level(SMD=-0.50,95%CI[-0.79,-0.21],P<0.0001),coronary angina attack frequency(SMD=-3.71,95%CI[-4.05,-3.36],P<0.0001)and duration of angina pectoris(SMD=-2.96,95%CI[-3.25,-2.66],P<0.0001),with statistically significant differences.But the differences in fasting plasma glucose(FPG)(SMD=-0.19,95%CI[-0.45,0.08],P=0.16),plasma glucose of two hours after meal(2hPG)(SMD=0.19,95%CI[-0.11,0.49],P=0.22),and high-density lipoprotein(HDL)level(SMD=0.10,95%CI[-0.30,0.49],P=0.62)after treatment were not statistically significant.Compared with the control group,there was no significant difference in adverse reactions(SMD=-2.96,95%CI[-3.25,-2.66],P=0.75).The existing evidence shows that the combination of Western medicine and Danhong Injection can improve the clinical effect for diabetes mellitus complicated with coronary heart disease and has no obvious adverse reactions.However,due to the low level of overall literature evidence,high risk and some kind of publication bias,it still needs more high-quality randomized controlled trials and low-bias studies for further verification.
Keywords:Danhong Injection  diabetes mellitus complicated with coronary heart disease  Meta-analysis  efficacy  safety
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号